mechanism of action of glp-1 receptor agonists GLP1 Agonists—Effects beyond Obesity and Diabetes Mechanism of action of GLP-1

Using the UK Biobank as a global reference of worldwide populations: application to measuring ancestry diversity from GWAS summary statistics

SURPASS-3 Compared tirzepatide with patients on metformin, with our without an SGLT-2 Inhibitor to Insulin degludec

Risk ratios (RR) for nonfatal stroke estimates according to direct (DPP-4 inhibitors, GLP-1RA and SGLT-2 inhibitors against placebo) and indirect (DPP-4 inhibitors vs GLP-1RA or SGLT-2 inhibitors, and GLP-1RA vs SGLT-2 inhibitors) comparisons

Sci 3 , 690705 (2020)

Neves JS, Borges-Canha M, Vasques-Nvoa F, Green JB, Leiter LA, Granger CB, et al

However, this landscape could shift next year with the anticipated approval of: The oral version of Wegovy for obesity treatment (approved just yesterday) Eli Lillys Orforglipron